Shilong Zhong
- Molecular Biology top 10%
- Cancer Research top 10%
- Surgery
- Cardiology and Cardiovascular Medicine top 10%
- Oncology
- Co-authors
- Jiyan ChenMin HuangWeihua LaiLan TangQian ZhuXiaohong ChenXi‐Yong YuShufeng Zhou
- Topics
- Lipoproteins and Cardiovascular Health (13 papers)Metabolomics and Mass Spectrometry Studies (11 papers)Pharmacogenetics and Drug Metabolism (10 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shilong Zhong
92 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 120
- Molecular Biology 770
- Cancer Research 269
- Surgery 231
- Cardiology and Cardiovascular Medicine 229
- Oncology 155
Countries citing papers authored by Shilong Zhong
This map shows the geographic impact of Shilong Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilong Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilong Zhong more than expected).
Fields of papers citing papers by Shilong Zhong
This network shows the impact of papers produced by Shilong Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilong Zhong. The network helps show where Shilong Zhong may publish in the future.
Co-authorship network of co-authors of Shilong Zhong
This figure shows the co-authorship network connecting the top 25 collaborators of Shilong Zhong. A scholar is included among the top collaborators of Shilong Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilong Zhong. Shilong Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 9 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 11 | |
| 7 | 19 | |
| 8 | 5 | |
| 9 | 34 | |
| 10 | 29 | |
| 11 | 23 | |
| 12 | 35 | |
| 13 | 15 | |
| 14 | 120 | |
| 15 | 5 | |
| 16 | 29 | |
| 17 | 8 | |
| 18 | 84 | |
| 19 | [Distribution of variant alleles association with warfarin pharmacokinetics and pharmacodynamics in the Han population in China]. | 4 |
| 20 | 22 |
About Shilong Zhong
Shilong Zhong is a scholar working on Pharmacology, Biochemistry and Cancer Research, having authored 99 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (13 papers), Metabolomics and Mass Spectrometry Studies (11 papers) and Pharmacogenetics and Drug Metabolism (10 papers). The work is most often cited by research in Cancer Research (269 citations), Pharmacology (144 citations) and Biological Psychiatry (31 citations). Shilong Zhong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jiyan Chen, Min Huang, Weihua Lai, Lan Tang, Qian Zhu, Xiaohong Chen, Xi‐Yong Yu, Shufeng Zhou, Xiaoping Chen and Marjorie Romkes. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.